MPNEsupport Org 802492-1069, Sweden
Melanoma Patient Network Europe
Last update 19th December 2019 BR
The ASCO guide to Melanoma written for patients, also covers therapy options for advanced Melanoma but is somewhat indiscriminate to new and old therapies- Interleukin and chemo mentioned in same line with immune therapies e.g. Sections are regularly reviewed and approved by the Cancer.Net Editorial Board.
(3) Forsea et al., 2012.Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol. 2012 Nov;167(5)
(4) Miller AJ, Mihm MC. Melanoma. N Engl J Med. 2006;355:51-65.
(5) National Comprehensive Cancer Network (2010), NCCN clinical practice guidelines in oncology(TM) - melanoma. V.2.2010.
(6) Globocan 2018
that starts from the pigment-producing cells of the body, called melanocytes. Often, Melanoma starts on the skin with a mole but in rarer occasions, it can also start in the eye, on hand and feet, any inner surface of the body or in extremely rare instances, in any organ of the body like the heart or the meninges (soft wrappings for the brain and spinal chord). When Melanoma is discovered at a stage when it has spread, it can become impossible to identify the place where it has started.
Discovered early, Melanomas can be removed by surgery and patients have a very high chance of being cured. Once spread, it is sometimes called Malignant Melanoma (although Melanoma is always cancer, so it is always malignant). Without new medicines, patients will on average only survive 6-9 months after diagnosis, highlighting the importance of access to the new effective Melanoma treatments for our community.
(1) Osterlind A. Epidemiology on malignant melanoma in Europe. Acta. Oncol. 1992;31(8):903-8.
(2) SEER, NCI